Companies / BioAge Labs, Inc.

BioAge Labs, Inc.

Nasdaq: BIOACIK 1709941EMERYVILLE, CA

Financials · FY2025

Revenue$8.99M
Net income$-80.61M
Total debt$0
Cash$73.96M
Diluted EPS$-2.24
Shares outstanding45.9M

Ownership

45.9M shares outstanding · as of Jul 31, 2026
2.2%Insiders
Ownership
Insiders2.21%1,013,524
10%+ / strategic4.45%2,040,605
Institutions61.40%28,180,335
Public float31.95%14,662,445

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Kristen FortneyCEOChief Executive Officer · Director
2.13%976,949
Goldstein Dov a MdChief Financial Officer
0.08%36,575
Rubin Paul DChief Medical Officer
0.00%0
Barton ShanePrincipal Accounting Officer
——
Enright Patrick GDirector
——
Garnier Jean PierreDirector
——
Healy JamesDirector
——
Morgen EricChief Operating Officer · Director
——

Institutional holders 121

View all →
HolderValue% of shares
BlackRock, Inc.$69.83M6.21%
a16z Capital Management, L.L.C.$44.07M7.04%
Janus Henderson Group PLC$36.60M4.56%
Sofinnova Investments, Inc.$30.35M5.00%
RA Capital Management, L.P.$28.87M3.60%
Cormorant Asset Management, LP$27.00M4.45%
State Street Corporation$25.04M2.23%
Balyasny Asset Management L.P.$23.22M2.89%
Octagon Capital Advisors LP$21.14M3.48%
Vanguard Group Inc$18.72M3.08%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 13, 2026Kristen Fortney
CEO
SellCommon Stock$4.22M-233K
-19.26%
976,949
2.13% of shares
medium
Jan 13, 2026Goldstein Dov a Md
Executive
SellCommon Stock$239.5K-12K
-32.40%
24,331
0.05% of shares
medium
Jan 13, 2026Goldstein Dov a Md
Executive
ExerciseCommon Stock$226.5K+27K
+120.49%
49,408
0.11% of shares
low
Jan 13, 2026Goldstein Dov a Md
Executive
SellCommon Stock$165.4K-9K
-18.16%
40,434
0.09% of shares
medium
Apr 1, 2026Rubin Paul D
Executive
SellCommon Stock$157.1K-9K
-100.00%
0
0.00% of shares
medium
Mar 2, 2026Rubin Paul D
Executive
SellCommon Stock$150.9K-7K
-100.00%
0
0.00% of shares
medium
Feb 2, 2026Rubin Paul D
Executive
SellCommon Stock$139.4K-7K
-100.00%
0
0.00% of shares
medium
Jan 2, 2026Rubin Paul D
Executive
SellCommon Stock$95.5K-7K
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Cormorant Asset Management, LPPassive13G/A—2,040,605—
Kristen FortneyPassive13G/A———
ADAR1 Capital Management, LLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BIOACommon StockEquity09077V100BBG00HBTB0M9